Clinical Research Directory
Browse clinical research sites, groups, and studies.
Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery
Sponsor: Nanjing Medical University
Summary
This study is a multicenter, randomized controlled, double-blind, placebo-controlled parallel trial designed to evaluate the effect of perioperative supplementation with Compound Vitamin B on patients undergoing cardiovascular surgery. A total of 1,000 patients aged 18-80 years who are scheduled to receive cardiovascular surgeries such as coronary artery bypass grafting (CABG) and valve replacement will be enrolled. They will be randomly assigned at a 1:1 ratio to either the experimental group (perioperative supplementation with Compound Vitamin B tablets, once daily from 3 days before surgery to 6 months after surgery) or the control group (oral placebo), with both groups receiving standardized perioperative treatment.
Official title: Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery: A Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
1000
Start Date
2026-02-01
Completion Date
2027-12-31
Last Updated
2026-01-16
Healthy Volunteers
No
Interventions
Compound Vitamin B tablet
perioperative supplementation with Compound Vitamin B tablets, once daily from 3 days before surgery to 6 months after surgery
Control
perioperative supplementation with placebo, once daily from 3 days before surgery to 6 months after surgery
Locations (2)
Shanghai East Hospital Tongji University
Shanghai, DR, China
The First Affiliated Hospital of Nanjing Medical University
Nanjing, China